Jun Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jun Chen has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Yunsu Wang
Department of Cardiology, Xiamen TCM Hospital Affiliated to Fujian University of Traditional Chinese Medicine, China
4 shared publications - Hanjing Jiang
Department of Cardiology, Xiamen TCM Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Xiamen, China
2 shared publications - Jian Li
Department of Cardiology, Xiamen TCM Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Xiamen, China
2 shared publications - Jingting Chen
Department of Cardiology, Xiamen TCM Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Xiamen, China
2 shared publications - Kailin Zheng
Department of Cardiology, Xiamen TCM Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Xiamen, China
2 shared publications - Zhantao Cao
Department of Cardiology, Xiamen TCM Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Xiamen, China
2 shared publications
Latest Publications
- Open Access
- 17 February 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Efficacy and safety of dual antiplatelet therapy de-escalation in East Asian individuals following percutaneous coronary intervention for acute coronary syndrome: a systematic review and meta-analysis
East Asian patients with acute coronary syndrome (ACS) are more prone to bleeding complications than Western populations under comparable antithrombotic re
- 17 February 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Open AccessEfficacy and safety of dual antiplatelet therapy de-escalation in East Asian individuals following percutaneous coronary intervention for acute coronary syndrome: a systematic review and meta-analysis
East Asian patients with acute coronary syndrome (ACS) are more prone to bleeding complications than Western populations under comparable antithrombotic re
- Open Access
- 19 December 2025
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 12, 1631493
Prognostic value of the neutrophil percentage-to-albumin ratio for mortality in ICU patients with myocardial infarction: a retrospective cohort and machine learning analysis
Background: Although the neutrophil percentage-to-albumin ratio (NPAR) has shown prognostic value in multiple clinical conditions, its prognostic accuracy for myocardial infarction (MI) patients receiving intensive care has yet to be clearly defined. To our knowledge, this study is the first to comprehensively evaluate the prognostic role of NPAR in ICU-admitted MI patients, integrating both conventional Cox regression and machine learning approaches to address an existing gap between general MI cohorts and critically ill populations. Method: Using data from the MIMIC-IV v3.1 database, we retrospectively included 1,759 ICU-admitted MI patients and calculated NPAR at admission. Primary and secondary outcomes were 30-day and 360-day all-cause mortality, respectively. Kaplan–Meier curves and log-rank tests compared survival across tertiles. Multivariate Cox models assessed associations, with restricted cubic splines evaluating nonlinearity. Machine learning models incorporating NPAR were developed to predict 30-day mortality, and model performance was assessed using the area under the receiver operating characteristic curve (AUC). Result: The 30-day and 360-day all-cause mortality rates were 24% and 38%, respectively. Kaplan–Meier analysis revealed significantly lower survival probabilities in patients with higher NPAR levels. Adjusted Cox regression showed that those in the highest NPAR tertile had an increased risk of 30-day (HR: 2.03, 95% CI: 1.51–2.73, p < 0.001) and 360-day (HR: 1.81, 95% CI: 1.45–2.26, p < 0.001) mortality. Machine learning models incorporating NPAR achieved an AUC of up to 0.81 for predicting 30-day death. Conclusion: The NPAR serves as an independent predictor of mortality at 30 and 360 days in MI patients admitted to the intensive care unit (ICU). When integrated into machine learning models, NPAR enhances predictive accuracy. These results indicate that NPAR serves as an independent predictor of short- and long-term mortality in ICU-admitted MI patients. Given its simplicity and accessibility from routine laboratory tests, NPAR can be feasibly incorporated into clinical decision-making and risk stratification protocols in critical care settings to facilitate individualized risk assessment and improve outcomes.
- 19 December 2025
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 12, 1631493
Open AccessPrognostic value of the neutrophil percentage-to-albumin ratio for mortality in ICU patients with myocardial infarction: a retrospective cohort and machine learning analysis
Background: Although the neutrophil percentage-to-albumin ratio (NPAR) has shown prognostic value in multiple clinical conditions, its prognostic accuracy for myocardial infarction (MI) patients receiving intensive care has yet to be clearly defined. To our knowledge, this study is the first to comprehensively evaluate the prognostic role of NPAR in ICU-admitted MI patients, integrating both conventional Cox regression and machine learning approaches to address an existing gap between general MI cohorts and critically ill populations. Method: Using data from the MIMIC-IV v3.1 database, we retrospectively included 1,759 ICU-admitted MI patients and calculated NPAR at admission. Primary and secondary outcomes were 30-day and 360-day all-cause mortality, respectively. Kaplan–Meier curves and log-rank tests compared survival across tertiles. Multivariate Cox models assessed associations, with restricted cubic splines evaluating nonlinearity. Machine learning models incorporating NPAR were developed to predict 30-day mortality, and model performance was assessed using the area under the receiver operating characteristic curve (AUC). Result: The 30-day and 360-day all-cause mortality rates were 24% and 38%, respectively. Kaplan–Meier analysis revealed significantly lower survival probabilities in patients with higher NPAR levels. Adjusted Cox regression showed that those in the highest NPAR tertile had an increased risk of 30-day (HR: 2.03, 95% CI: 1.51–2.73, p < 0.001) and 360-day (HR: 1.81, 95% CI: 1.45–2.26, p < 0.001) mortality. Machine learning models incorporating NPAR achieved an AUC of up to 0.81 for predicting 30-day death. Conclusion: The NPAR serves as an independent predictor of mortality at 30 and 360 days in MI patients admitted to the intensive care unit (ICU). When integrated into machine learning models, NPAR enhances predictive accuracy. These results indicate that NPAR serves as an independent predictor of short- and long-term mortality in ICU-admitted MI patients. Given its simplicity and accessibility from routine laboratory tests, NPAR can be feasibly incorporated into clinical decision-making and risk stratification protocols in critical care settings to facilitate individualized risk assessment and improve outcomes.
- Open Access
- 20 August 2025
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 26 (8) , 43942
Association Between the Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score and Adverse Outcomes in Critically Ill Patients With Acute Myocardial Infarction: A Retrospective Study and Machine Learning Analysis
Background: The hemoglobin, albumin, lymphocyte, and platelet (HALP) score represents a meaningful predictor in many cardiovascular diseases. However, the predictive utility of this score for the outcome of patients admitted to the intensive care unit (ICU) due to acute myocardial infarction (AMI) has yet to be fully elucidated. Methods: Information from the Medical Information Mart for Intensive Care (MIMIC)-IV v3.1 database was used to analyze the association between the HALP score and 90 days and 365 days all-cause mortality in critically ill patients with AMI. Patients were grouped according to the calculated HALP quartiles. Cox proportional hazards regression analysis and restricted cubic spline (RCS) analysis were performed to assess the association between the HALP score and mortality risk. A recursive algorithm identified the HALP inflection point, thus defining high and low HALP groups for the Kaplan–Meier survival analysis. Subgroup analyses analyzed the robustness across clinical strata. Furthermore, predictive models based on machine learning algorithms that included the HALP score were constructed to estimate 90 days mortality. The performance of the models was evaluated using the area under the receiver operating characteristic curve (AUC). Results: A total of 818 AMI patients were included. The analysis revealed mortality rates of 31% at 90 days and 40% at 365 days. Elevated HALP values were independently linked to a reduced risk of death. In fully adjusted models, patients in the top HALP quartile exhibited significantly lower all-cause mortality at 90 days (hazard ratio (HR) = 0.68; 95% confidence interval (CI): 0.47–0.99; p = 0.047) and 365 days (HR = 0.66; 95% CI: 0.47–0.90; p = 0.011). A nonlinear, inverse “L-shaped” association was observed, with an inflection point identified at a HALP value of 19.41. Below this value, each unit increase in the HALP score reduced mortality risk by 2.4%–2.7%. The Kaplan–Meier curves confirmed an improved survival above the threshold. Meanwhile, the subgroup analyses revealed a generally consistent association between the HALP score and mortality, except for age, where a significant interaction was observed (p = 0.003), indicating a stronger protective effect in older patients. Machine learning analyses supported the robustness and predictive value of the HALP score, with a maximum AUC of 0.7804. Conclusions: The HALP score is significantly associated with all-cause mortality among critically ill individuals suffering from AMI.
- 20 August 2025
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 26 (8) , 43942
Open AccessAssociation Between the Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score and Adverse Outcomes in Critically Ill Patients With Acute Myocardial Infarction: A Retrospective Study and Machine Learning Analysis
Background: The hemoglobin, albumin, lymphocyte, and platelet (HALP) score represents a meaningful predictor in many cardiovascular diseases. However, the predictive utility of this score for the outcome of patients admitted to the intensive care unit (ICU) due to acute myocardial infarction (AMI) has yet to be fully elucidated. Methods: Information from the Medical Information Mart for Intensive Care (MIMIC)-IV v3.1 database was used to analyze the association between the HALP score and 90 days and 365 days all-cause mortality in critically ill patients with AMI. Patients were grouped according to the calculated HALP quartiles. Cox proportional hazards regression analysis and restricted cubic spline (RCS) analysis were performed to assess the association between the HALP score and mortality risk. A recursive algorithm identified the HALP inflection point, thus defining high and low HALP groups for the Kaplan–Meier survival analysis. Subgroup analyses analyzed the robustness across clinical strata. Furthermore, predictive models based on machine learning algorithms that included the HALP score were constructed to estimate 90 days mortality. The performance of the models was evaluated using the area under the receiver operating characteristic curve (AUC). Results: A total of 818 AMI patients were included. The analysis revealed mortality rates of 31% at 90 days and 40% at 365 days. Elevated HALP values were independently linked to a reduced risk of death. In fully adjusted models, patients in the top HALP quartile exhibited significantly lower all-cause mortality at 90 days (hazard ratio (HR) = 0.68; 95% confidence interval (CI): 0.47–0.99; p = 0.047) and 365 days (HR = 0.66; 95% CI: 0.47–0.90; p = 0.011). A nonlinear, inverse “L-shaped” association was observed, with an inflection point identified at a HALP value of 19.41. Below this value, each unit increase in the HALP score reduced mortality risk by 2.4%–2.7%. The Kaplan–Meier curves confirmed an improved survival above the threshold. Meanwhile, the subgroup analyses revealed a generally consistent association between the HALP score and mortality, except for age, where a significant interaction was observed (p = 0.003), indicating a stronger protective effect in older patients. Machine learning analyses supported the robustness and predictive value of the HALP score, with a maximum AUC of 0.7804. Conclusions: The HALP score is significantly associated with all-cause mortality among critically ill individuals suffering from AMI.
- 19 June 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (8) , 3327-3328
Comments on: Frailty Index as a Predictor of Operative Safety and Efficacy in Patients Undergoing Laparoscopic Sleeve Gastrectomy
- 19 June 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (8) , 3327-3328
Comments on: Frailty Index as a Predictor of Operative Safety and Efficacy in Patients Undergoing Laparoscopic Sleeve Gastrectomy